Clinical investigation of anti-fungal strategies in patients under aggressive treatment of hematological malignancies

• Conditions: Z94.80; B44; C92; D46.9; Aspergillosis; Myeloid leukaemia; Myelodysplastic syndrome, unspecified

• Registration Number: DRKS00000347
• Lead Sponsor: niklinik Freiburg Häm/Onk

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2010-12-31
• Study Start: 2012-07-10
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 220

Inclusion Criteria

allogeneic hämatopoetich cell transplantation
Induktiontherapy acute leucemia
consolidation therapy acute leucemia

Exclusion Criteria

no

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Incidence of breaktrough fungal infection after empirical, prophylactic and preemptive antimykotic therapy

Secondary Outcome Measures

Name	Time	Method
costeffectiveness therapy and diagnostic of antifungal drugs